Literature DB >> 10747253

Frequency of Escherichia coli strains producing the cytotoxic necrotizing factor (CNF1) in nosocomial urinary tract infections.

L Landraud1, M Gauthier, T Fosse, P Boquet.   

Abstract

The presence of cytotoxic necrotizing factor 1 (CNF1), together with various associated virulence factors (alpha-haemolysin, P-, S- and A-fimbriae), was screened in 175 uropathogenic Escherichia coli strains isolated from hospitalized adult patients. The cnf1 gene was detected in 30% of the selected strains independently of the severity of the clinical urinary infection. A significant association between CNF1, haemolytic activity and the products of the pap/sfa genes was found. However, CNF1 appeared not to play a major role in nosocomial E. coli urinary tract infections.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10747253     DOI: 10.1046/j.1472-765x.2000.00698.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  22 in total

1.  Antibodies against hemolysin and cytotoxic necrotizing factor type 1 (CNF1) reduce bladder inflammation in a mouse model of urinary tract infection with toxigenic uropathogenic Escherichia coli.

Authors:  Mark A Smith; Rebecca A Weingarten; Lisa M Russo; Christy L Ventura; Alison D O'Brien
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

2.  Cytotoxic necrotizing factor 1 prevents apoptosis via the Akt/IkappaB kinase pathway: role of nuclear factor-kappaB and Bcl-2.

Authors:  Alessandro Giamboi Miraglia; Sara Travaglione; Stefania Meschini; Loredana Falzano; Paola Matarrese; Maria Giovanna Quaranta; Marina Viora; Carla Fiorentini; Alessia Fabbri
Journal:  Mol Biol Cell       Date:  2007-05-16       Impact factor: 4.138

Review 3.  Bacterial factors exploit eukaryotic Rho GTPase signaling cascades to promote invasion and proliferation within their host.

Authors:  Michel R Popoff
Journal:  Small GTPases       Date:  2014-05-08

4.  Occurrence and genetic association of selected virulence factors in clinical Escherichia coli isolates.

Authors:  E Bogyiová; L Siegfried; M Kmetová; Z Sándorcínová; A Liptáková; E Biros
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

5.  Characterization of hemolytic Escherichia coli strains in ferrets: recognition of candidate virulence factor CNF1.

Authors:  Robert P Marini; Nancy S Taylor; Alvin Y Liang; Kimberly A Knox; Jeremy Andrew Peña; David B Schauer; James G Fox
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

6.  Genotoxic Escherichia coli Strains Encoding Colibactin, Cytolethal Distending Toxin, and Cytotoxic Necrotizing Factor in Laboratory Rats.

Authors:  Susanna A Kurnick; Anthony J Mannion; Yan Feng; Carolyn M Madden; Paul Chamberlain; James G Fox
Journal:  Comp Med       Date:  2019-03-22       Impact factor: 0.982

7.  Cytotoxic necrotizing factor 1 and hemolysin from uropathogenic Escherichia coli elicit different host responses in the murine bladder.

Authors:  Tamako A Garcia; Christy L Ventura; Mark A Smith; D Scott Merrell; Alison D O'Brien
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

8.  Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice.

Authors:  Yarery C Smith; Susan B Rasmussen; Kerian K Grande; Richard M Conran; Alison D O'Brien
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

9.  Virulence properties of uropathogenic Escherichia coli isolated from children with urinary tract infection in Korea.

Authors:  Dong Ho Kim; Bindu Subhadra; Hee Young Kang; Kyungho Woo; Jaeseok Kim; Yeo-Jin Son; Kyung Mok Sohn; Hwa-Jung Kim; Kyudong Han; Man Hwan Oh; Chul Hee Choi
Journal:  Genes Genomics       Date:  2018-02-14       Impact factor: 1.839

10.  Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli.

Authors:  Travis J Wiles; Jean M Bower; Michael J Redd; Matthew A Mulvey
Journal:  PLoS Pathog       Date:  2009-12-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.